Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci.
about
Cancer diagnostic classifiers based on quantitative DNA methylationEmerging critical role of molecular testing in diagnostic genitourinary pathologyValidation study of genes with hypermethylated promoter regions associated with prostate cancer recurrence.The Ras-association domain family (RASSF) members and their role in human tumourigenesis.Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors.DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage.X-linked ectodermal dysplasia receptor is downregulated in breast cancer via promoter methylation.TGF-β mediated DNA methylation in prostate cancer.Prognostic Value of Promoter Hypermethylation of Retinoic Acid Receptor Beta (RARB) and CDKN2 (p16/MTS1) in Prostate CancerAssociation between RASSF1A promoter methylation and prostate cancer: a systematic review and meta-analysis.Aberrant DNA methylation and prostate cancer.DNA methylation changes in prostate cancer: current developments and future clinical implementation.Genetic and epigenetic changes in human prostate cancerPyrosequencing Analysis of APC Methylation Level in Human Prostate Tissues: A Molecular Marker for Prostate Cancer.Epigenetic analysis of microRNA genes in tumors from surgically resected lung cancer patients and association with survivalGene methylation and early detection of genitourinary cancer: the road ahead.High quality assessment of DNA methylation in archival tissues from colorectal cancer patients using quantitative high-resolution melting analysis.CpG island hypermethylation profile in the serum of men with clinically localized and hormone refractory metastatic prostate cancer.BPH and prostate cancer risk.Promoter hypermethylation in prostate cancer.Hypomethylating agents for urologic cancers.APC gene hypermethylation and prostate cancer: a systematic review and meta-analysis.Molecular biomarkers in prostate cancer.Methylation markers for prostate cancer prognosis: a systematic review.Prostate cancer epigenetic biomarkers: next-generation technologies.Prognostic DNA methylation markers for prostate cancer.Pan-cancer patterns of DNA methylation.Using nanobiotechnology to increase the prevalence of epigenotyping assays in precision medicine.Prospective Study of CRMP4 Promoter Methylation in Prostate Biopsies as a Predictor For Lymph Node Metastases.High pesticide exposure events and DNA methylation among pesticide applicators in the agricultural health study.Diagnostic utility of aberrant methylation of tissue factor pathway inhibitor 2 in pure pancreatic juice for pancreatic carcinoma.DNA methylation changes correlate with Gleason score and tumor stage in prostate cancer.Frequent DNA Hypermethylation at the RASSF1A and APC Gene Loci in Prostate Cancer Patients of Pakistani Origin.DNA methylation in promoter region as biomarkers in prostate cancer.The association between RASSF1A promoter methylation and prostate cancer: evidence from 19 published studies.HOXA9, ISL1 and ALDH1A3 methylation patterns as prognostic markers for nonmuscle invasive bladder cancer: array-based DNA methylation and expression profiling.Transgenerational effects of the endocrine disruptor vinclozolin on the prostate transcriptome and adult onset disease.Markers of clinical utility in the differential diagnosis and prognosis of prostate cancer.Combined hypermethylation of APC and GSTP1 as a molecular marker for prostate cancer: quantitative pyrosequencing analysis.
P2860
Q27012960-F4FD3D44-8C15-491E-8B03-C95CB4EAA242Q27021371-4D37895E-5CD5-4459-86F0-26980B71A374Q30582750-3254BC9D-B6C3-4B5E-8BE4-9EFD5F30BDADQ31121564-B470C63C-6357-4F54-BEF0-8D6361EEAFDBQ33291459-7EA4069C-86EA-45F6-8011-D10F7CC4450DQ33372943-40A3A9E2-982A-447F-89F3-1AEA5002BBC9Q33658266-1667003B-B3A4-40E0-BCC1-4098B13174C9Q34039935-6312F3C5-F576-4BAC-8156-FDF9881F3DB4Q34324983-6E0D1276-9222-4471-85DC-42517A146557Q35000853-A7ED3172-EB3C-4364-B33F-D2344322C58BQ35560819-F8482A7A-01A2-4D7C-9A0A-E4261518BA0FQ35636543-D57769E6-9935-493A-8181-A73754A1F6BFQ36022274-17D592CC-C160-49D3-8888-3A5A4E48FC2AQ36705589-A6702B10-B7F3-4CC3-940A-F56148AA38D9Q36746000-4B06236F-F293-487E-9B9D-EB6E45F27126Q36856466-5F73C901-DCDA-4728-861D-16D4BCA6A8F0Q37151097-54791D66-197F-4649-B78D-F76BB6A75FB9Q37243155-DA906C69-7610-4D2E-9278-B4687E64115EQ37707775-B105F85E-0C19-4183-ABC9-981F7588C637Q37791396-0F7D4A82-FF50-4906-8268-822547E7212EQ37854737-E8E4DAC3-D1CB-4766-AFD7-129DABB3BF1CQ38072660-FE7E7DAB-41F1-42B5-B1D5-D892C93E0126Q38088854-3F5BA802-6555-42C2-8D2A-C3E9387E634CQ38116745-CDCAE7A2-CE8E-4350-A7F5-80DE01567FD6Q38212471-6C2013CD-136F-4841-93AB-EF5F5D306E80Q38252624-925A65E4-DE31-4937-A4EE-FA46FEA06720Q38282894-53B2EBAB-28BE-4C8B-B12D-C5AE4750E258Q38820366-E37891F3-3566-4A7D-A9F1-6B96E9CFC4F0Q38998986-C0FF5215-2C88-4113-93CC-25742BF2BCBBQ39084419-8853308A-0141-47BC-A707-300985DC89B1Q40233356-9617DFEB-C73B-4089-8B2F-1B0E9272C51DQ40848507-5F1C4403-DB7C-4D78-B634-76CCB1174822Q41845384-903D6F60-3B51-4514-805B-759E04BFA0E8Q42261678-E3496CA8-811F-43F8-8883-109AF3AD2F1CQ44538170-B1FEB513-5FAB-45D8-95A2-C76F230CB0AEQ45716446-812AEB83-D4F9-47A4-9853-58BBFED8C4F4Q46791384-68EDB438-ABE9-4D93-AD13-1D24E511EAC2Q47215343-711AF036-6A46-4F28-8C2A-7F6B825B24D6Q50950930-7BB22F29-B18C-4CFC-B5CB-5F0850AAD5FB
P2860
Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Diagnostic and prognostic info ...... of hypermethylated gene loci.
@en
type
label
Diagnostic and prognostic info ...... of hypermethylated gene loci.
@en
prefLabel
Diagnostic and prognostic info ...... of hypermethylated gene loci.
@en
P2093
P1476
Diagnostic and prognostic info ...... t of hypermethylated gene loci
@en
P2093
Alexander von Ruecker
Axel Wellmann
Jörg Ellinger
Nicolas Wernert
Patrick J Bastian
Stefan C Müller
P304
P356
10.1158/1078-0432.CCR-04-1832
P407
P577
2005-06-01T00:00:00Z